文献速递骨质疏松与钙磷/甲状旁腺肥胖与代谢综合征

维生素D与社区老年女性衰弱及衰弱进展的关系

Association Between Vitamin D, Frailty, and Progression of Frailty in Community-Dwelling Older Women.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

瑞典马尔默前瞻性人群队列研究,纳入75岁社区女性1044例,在80岁和85岁随访。结果显示75岁和80岁时25OHD不足(<50 nmol/L)者衰弱指数更高,80岁时不足与5年后衰弱相关,但未发现加速进展关联,85岁时无关联。

要点

  • 75岁和80岁女性25OHD不足者衰弱指数显著高于充足者。
  • 80岁时25OHD不足与5年后衰弱相关,但未发现加速进展关联。
  • 85岁女性中未观察到25OHD与衰弱的关联。

核心结论

  • 在社区老年女性中,25OHD不足与衰弱增加相关,但这一关联在85岁最年长组中未观察到。
  • 维持充足25OHD水平可能对健康老龄化有价值。

研究设计与样本

  • 前瞻性、基于人群的队列研究,地点为瑞典马尔默。
  • 纳入75岁社区居住女性1044例,80岁时重评估715例,85岁时重评估382例。
  • 衰弱用10变量衰弱指数量化,25OHD分为不足(<50 nmol/L)和充足(≥50 nmol/L)。

主要发现

  • 75岁时25OHD不足者衰弱指数为0.23,充足者为0.18(P < 0.001)。
  • 80岁时25OHD不足者衰弱指数为0.32,充足者为0.25(P = 0.001)。
  • 80岁时25OHD不足与5年后衰弱相关(0.41 vs 0.32;P = 0.011)。
  • 未发现较低25OHD水平与衰弱加速进展相关,25OHD >75 nmol/L未显示额外获益。
  • 85岁时未观察到25OHD与衰弱的关联;衰弱指数中与25OHD相关的变量涉及肌肉力量和功能。

关键数值与推荐

  • 25OHD不足定义为<50 nmol/L,充足定义为≥50 nmol/L。
  • 衰弱指数为10变量量表,用于量化衰弱程度。

临床怎么用

  • 对75岁和80岁社区老年女性,可关注25OHD水平,维持≥50 nmol/L可能有助于降低衰弱风险。
  • 85岁及以上女性中25OHD与衰弱的关联不显著,临床决策需结合个体情况。

局限性

  • 研究仅纳入社区居住女性,结果外推至男性或其他人群需谨慎。
  • 随访至85岁时样本量减少至382例,可能影响该年龄组统计效能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Vitamin D (25OHD) is involved in many physiological functions that decline with age, contributing to frailty and increased risk for negative health outcomes. Whether 25OHD is a long-term risk marker for frailty over a longer time and whether it is consistent with advancing age is unclear. OBJECTIVE: To investigate the association between 25OHD and frailty in older women followed for 10 years. DESIGN AND SETTING: Prospective, population-based, cohort study in Malmö, Sweden. PARTICIPANTS: Community-dwelling women, age 75 years (N = 1044) with reassessments at ages 80 (n = 715) and 85 (n = 382) years. METHODS: Frailty was quantified using a 10-variable frailty index. Women were categorized as 25OHD insufficient (<50 nmol/L) or sufficient (≥50 nmol/L). RESULTS: At ages 75 and 80 years, women with insufficient 25OHD were frailer than women with sufficient 25OHD (0.23 vs 0.18, P < 0.001; and 0.32 vs 0.25, P = 0.001, respectively). At age 80 years, 25OHD insufficiency was associated with subsequent frailty 5 years later (0.41 vs 0.32; P = 0.011). Accelerated progression of frailty was not associated with lower 25OHD levels, and 25OHD level >75 nmol/L was not additionally beneficial with regard to frailty. No association between 25OHD and frailty was observed at age 85 years. Within the frailty index, variables associated with 25OHD were related to muscle strength and function. CONCLUSION: In this study, 25OHD insufficiency was associated with increased frailty in all but the oldest old. This study supports the value of maintaining sufficient 25OHD levels for healthy aging.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Buchebner D, Bartosch P, Malmgren L, et al. Association Between Vitamin D, Frailty, and Progression of Frailty in Community-Dwelling Older Women. J Clin Endocrinol Metab. 2019. PMID: 31287540. doi:10.1210/jc.2019-00573

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。